Liquidia Corporation
LQDA
Rank in Stocks
#4837
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating... Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
Share Price
$34.12
Last synced: 2026-10-19
Market Cap
$3.05B
Change (1 day)
-0.67%
Change (1 year)
39.61%
Country
US
Trade Liquidia Corporation (LQDA)
Category
Healthcare
Stock split history for Liquidia Corporation (LQDA)
Liquidia Corporation stock (symbol: LQDA) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One LQDA share bought prior to Oct 20, 2026 would equal to 0 LQDA shares today.
The most recent stock split occurred on Oct 20, 2026.
One LQDA share bought prior to Oct 20, 2026 would equal to 0 LQDA shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 0 | - |
US
|
|
| 0 | - |
SE
|
|
| 0 | - |
FR
|
|
| 0 | - |
IT
|
|
| 7 | x40 |
HK
|
